Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,065 public trials 1,848 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations
  • Massachusetts General Hospital . Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Active, not recruiting

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

NCT05740566

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California Los Angeles Santa Monica, California, United States
View all 223 locations
View Trial Details
Active, not recruiting

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NCT04367311

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Summit Health Berkeley Heights, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, not recruiting

Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)

NCT05609968

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Infirmary Cancer Care ( Site 0418) Mobile, Alabama, United States
  • Profound Research LLC ( Site 0444) Oceanside, California, United States
  • Clermont Oncology Center ( Site 0421) Clermont, Florida, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0417) Miami, Florida, United States
View all 180 locations
View Trial Details
Active, not recruiting

SP Thoracic IDE Study

NCT05150210

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Benign Lung Disease, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions